Neurodegeneration and Neuroprotection in Parkinson Disease
Summary: Many of the motoric features that define Parkinson disease (PD) result primarily from the loss of the neuromelanin (NM)-containing dopamine (DA) neurons of the substantia nigra (SN), and to a lesser extent, other mostly catecholaminergic neurons, and are associated with cytoplasmic “Lewy bo...
Enregistré dans:
| Publié dans: | NeuroRx |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Am. Soc. for Experimental NeuroTherapeutics
2004
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC534919/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15717014/ https://ncbi.nlm.nih.govhttps://doi.org/10.1602/neurorx.1.1.139 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|